TB-500 10mg

Research applications

• Actin polymerisation and cytoskeletal regulation research
• Cell migration studies in wound-healing models
• Rodent models of tissue repair and injury recovery
• Angiogenesis and cell-signalling research

What the literature reports on thymosin beta-4 / TB-500

Thymosin beta-4 is a small, highly conserved protein that binds monomeric G-actin, regulating the pool of actin available for polymerisation into filaments. This core biochemical function, documented extensively in cell-biology literature, underlies its relevance to any process requiring rapid cytoskeletal remodelling, including cell migration and tissue repair.

Cell migration research

Because actin dynamics govern cell motility, in vitro studies have reported that thymosin beta-4 promotes the migration of several cell types implicated in wound healing, including endothelial cells and keratinocytes. This research has been extended to angiogenesis studies, where reported effects on endothelial cell migration are linked to new blood vessel formation in injury models.

Tissue repair models

Rodent studies have examined thymosin beta-4 administration in models of cutaneous wound healing, corneal injury and cardiac tissue injury, with research reporting effects on markers of repair and reduced fibrotic scarring in some of these models. This body of work spans multiple independent research groups and several distinct organ-injury contexts.

Naming and identity note

Researchers sourcing material under the name "TB-500" should be aware that published analytical chemistry work has, in at least one instance, identified material sold under this name as a shorter seven-residue actin-binding fragment (Ac-LKKTETQ) rather than the full 43-residue protein. This catalogue entry corresponds to the full-length thymosin beta-4 sequence; researchers requiring analytical certainty on the specific fragment length should consult the batch certificate of analysis.

Comparative tissue-repair research

Thymosin beta-4 research is frequently discussed alongside BPC-157 in the tissue-repair literature, given overlapping study endpoints in musculoskeletal and dermal injury models despite distinct proposed mechanisms of action, with comparative research used to characterise the relative contribution of cytoskeletal-regulation pathways to overall repair outcomes.

Laboratory handling

TB-500 should be stored as lyophilised powder at -20°C, protected from light and moisture, until reconstitution. Reconstitution follows standard peptide practice: diluent introduced slowly along the vial wall, followed by gentle mixing.

• Lyophilised powder: store at -20°C, protected from light, until reconstitution.
• Reconstitution: introduce diluent slowly along the vial wall; mix gently, do not shake.
• Post-reconstitution: 2-8°C for short-term laboratory use; avoid repeated freeze-thaw cycles.
• Each batch ships with a certificate of analysis confirming ≥99% purity by HPLC and identity by mass spectrometry.

See the peptide reconstitution and storage guide for a full protocol reference. This product is intended for laboratory research use only.